Health Condition 1: H522- Astigmatism
Conditions
Interventions
Intervention1: Atropine: Atropine 0.01% eyedrops 1 drop HS in the randomised eye for 1 year
Control Intervention1: NIL: Atropine eyedrops will be used only in one eye of each patient.Te other eye will
Sponsors
DrAbraham Kurian
Eligibility
Inclusion criteria
Inclusion criteria: 1. Children or Young adults in the age group 5-15 years. 2. Myopic refractive error of spherical equivalent > 1.00D as measured by cycloplegic refraction 3. Astigmatism of > 1.50D as measured by cycloplegic refraction 4. Documented progression of myopic component of Compound Myopic astigmatism 5. Ability to understand and follow the study instructions you receive and likely to be amenable for 1 year followup. 6. Normal ocular health other than refractive error 7. Normal Intraocular pressure (
Exclusion criteria
Exclusion criteria: 1. Known Allergy or hypersensitivity to Atropine, Cyclopentolate, Phenyl ephrine or Proparacaine 2. Amblyopia in atleast one eye 3. History of significant cardiac or respiratory illness 4. Current enrolment in another investigational study or participation in such a study within 30 days of entry into this study 5. No previous or current use of contact lenses or bifocals or progressive lenses or other forms of treatment (including Atropine in any strength) for myopia 6. Patient has a condition or situation which in the investigators opinion, may put the patient at a significant risk, may confound the study results, or interfere with the participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be progression of the myopic component of Compound Myopic astigmatism estimated as the change in spherical equivalent refractive error relative to the baselineTimepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary outcome will be the change in axial length with respect to the baseline measurement.Timepoint: 1 year | — |
Countries
India
Contacts
Public ContactDr Iodine Reghunadhan
Chaithanya Eye Hospital and Research Institute
Outcome results
None listed